Tables at a glance

Table 1

Table 2

Table 3

Table 4

Table 5

Figures at a glance

Figure 1

Figure 2

Table 1

RET-He Cut-off <30.4 pg	TSAT <20%, serum Iron <40 μg/dL (Protocol Values) (A)	TSAT <30%, serum Ironvalues)(B)
Sensitivity %	67.4	67.8
Specificity %	64.5	68
Negative Predictive Value (NPV)%	61.2	58.6
Positive Predictive Value (PPV)%	70.67	75.9

Table : Abstract table

Table 2

Characteristic	Male (Mean±SD)	Female (Mean±SD)
No. of patients	88 (35.3%)	161 (64.6%)
Age in years	61.8 ±10.3a	54.0 ±12.4a
Hb (g/dl)	8.6 ± 0.81	8.6 ± 0.79
MCV (fl)	85.4 ± 8.0	86.3 ± 7.6
RET-He (pg/cell)	29.7 ± 5	29.8 ± 4.7
Serum Iron (µg/dl)	38.1 ± 16.1	37.8 ± 16.6
Transferrin Saturation %	15.6 ± 6.8	15.2 ± 6.4
Ferritin (ng/ml)	296.5 ± 328.2	418.8 ± 621.5

Table 1: Study population characteristics*

Table 3

RET-He Cut-off <30.4 pg	TSAT <20%, serum Iron <40 µg/dL (Protocol Values) (A)	TSAT <30%, serum Iron <40 µg/dL(In house values)(B)
Sensitivity %	67.4	67.8
Specificity %	64.5	68
Negative Predictive Value (NPV)%	61.2	58.6
Positive Predictive Value (PPV)%	70.67	75.9

Table 2: Gamma passing rates for the various IMRT plans and different verifications

Table 4

RET-He Cut-off <31 pg	TSAT <20%, serum Iron <40 µg/dL (Protocol Values)(A)	TSAT <30%, serum Iron <40 µg/dL(In house values)(B)
Sensitivity %	74.1	73.8
Specificity %	60	63
Negative Predictive Value (NPV)%	64.7	61.7
Positive Predictive Value (PPV)%	70	74.8

* RET-He cut-off value established by Peerschke et al [15]
Table 3: Comparative Role of RET-He <31 pg *in the evaluation of Iron Deficiency (ID) in CRA patients (n=249)

Table 5

RET-He Cut-off <32 pg	TSAT <20%, serum Iron <40 µg/dL (Protocol Values) (A)	TSAT <30%, serum Iron <40 µg/dL(In house values)(B)
Sensitivity %	80.6	79.9
Specificity %	55.5	58
Negative Predictive Value (NPV)%	69.3	65.9
Positive Predictive Value (PPV)%	69.7	73.9
P value	<0.001	<0.001

* RET-He cut-off value established by Peerschke et al [15]
Table 4: Comparative Role of RET-He <32* in the evaluation of Iron Deficiency (ID) in CRA patients (n=249)

FIGURE 1

Figure 1: Distribution of RET-He

FIGURE 2

Figure 2: ROC Curve for RET-He cut-off value in CRA patients with ID (n=249)